Symbol="CLNN"
AssetType="Common Stock"
Name="Clene Inc."
Description="Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah."
CIK="1822791"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="103578000"
EBITDA="-44579000"
PERatio="None"
PEGRatio="None"
BookValue="-0.021"
DividendPerShare="0"
DividendYield="0"
EPS="-0.4"
RevenuePerShareTTM="0.008"
ProfitMargin="0"
OperatingMarginTTM="-83.28"
ReturnOnAssetsTTM="-0.614"
ReturnOnEquityTTM="-145.3"
RevenueTTM="550000"
GrossProfitTTM="447000"
DilutedEPSTTM="-0.4"
QuarterlyEarningsGrowthYOY="0.614"
QuarterlyRevenueGrowthYOY="2.567"
AnalystTargetPrice="6.43"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="187.08"
PriceToBookRatio="108.2"
EVToRevenue="204.48"
EVToEBITDA="-4.274"
Beta="0.329"
num_52WeekHigh="5.13"
num_52WeekLow="0.71"
num_50DayMovingAverage="0.939"
num_200DayMovingAverage="1.219"
SharesOutstanding="128397000"
DividendDate="None"
ExDividendDate="None"
symbol="CLNN"
open="0.83"
high="0.84"
low="0.80"
price="0.81"
volume="1011521.00"
latest_trading_day="2023-07-10"
previous_close="0.82"
change="-0.02"
change_percent="-1.8891%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="62"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="486059"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.71"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_negative_thumbnail_id_2="1143"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="703"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_positive_thumbnail_id_2="706"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
